Overview

To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
To demonstrate the bioequivalence of Azithromycin 600 mg Tablets Under Fed Conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Azithromycin